Immutep reports strong response rate from immunotherapies treating carcinomas
Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TPN | Just joined the register | 03/09/14 | 14 | 4.5K | |||
|
|||||||
TPN | Ann: Change of ASX Code | 10:54 | 0 | 1.1K | |||
|
|||||||
TPN | Ann: Becoming a substantial holder | 08/08/14 | 0 | 573 | |||
|
|||||||
TPN | Some thoughts on the prospectus | 05/08/14 | 2 | 1.5K | |||
|
|||||||
TPN | Report coming in August | 03/08/14 | 1 | 1.2K | |||
|
|||||||
TPN +CBA | Ann: Change in substantial holding from CBA | 24/07/14 | 0 | 744 | |||
|
|||||||
TPN +CBA | Ann: Becoming a substantial holder from CBA | 24/07/14 | 0 | 800 | |||
|
|||||||
TPN +NAB | Ann: Becoming a substantial holder from NAB | 17/07/14 | 0 | 769 | |||
|
See All Discussions